Virtual Exhibit Hall
Premier Partner: AbbVie
Blue Earth Diagnostics
Blue Earth Diagnostics, a subsidiary of Bracco Imaging, is a recognized leader in the development and commercialization of novel PET radiopharmaceuticals to inform clinical management for cancer patients. Its portfolio includes a commercial product for recurrent prostate cancer and a robust pipeline of investigational agents.
We’re Janssen Oncology. We’re shaping the future of cancer treatment by providing transformative solutions that help alter the way cancers are treated, with the ultimate goal of identifying curative therapies. As a leader, we’re committed to focusing on the wholistic needs of those who rely on our therapies to improve overall experience and outcomes that will change what a cancer diagnosis means. Together with our partners, we are focused on delivering solutions that make a positive impact on human health. This is our promise.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.